HIGHLIGHTS
- What: The aim of this study is to assess ONSD changes when clinical remission is achieved in patients with GCA. The authors aimed to detect a reduction of 1.5 mm in ONSD in participants with GCA after 3 months of therapy, with a power of 0.8 and a type 1 error of 0.05. The study design was prospective, with systematic, standardized data collection and study procedures.
- Who: Carolyn Ross from the Vasculitis Clinic, Department of Medicine, Sacre‑Coeur Hospital, University of Montreal, Montreal, QC, Canada have published the research work: Optic nerve . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.